...
首页> 外文期刊>Tissue antigens. >HLA-DRB1, -DQB1 alleles in head and neck carcinoma patients.
【24h】

HLA-DRB1, -DQB1 alleles in head and neck carcinoma patients.

机译:头颈部癌患者中的HLA-DRB1,-DQB1等位基因。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Certain HLA class II alleles have been reported to play a role in development or prevention of cervical carcinoma, an epithelial malignancy linked to human papillomavirus (HPV). In head and neck carcinomas, of which a subset is also HPV associated, the impact of HLA genes remains unknown. HLA-DRB1, -DQB1 alleles were determined in a comprehensive series of 162 head and neck carcinoma patients, for which 83 consecutive cadaveric organ donors of Finnish origin served as controls. DRB1*03 was associated with node-negative disease and DRB1*08 and 13 with small tumors; DRB1*04 was protective against disease relapse. Most alleles of borderline significance in this study act similarly in cervical carcinomas.
机译:据报道,某些HLA II类等位基因在宫颈癌的发展或预防中起作用,宫颈癌是与人乳头瘤病毒(HPV)相关的上皮恶性肿瘤。在子宫颈癌也与HPV相关的头颈癌中,HLA基因的影响仍然未知。 HLA-DRB1,-DQB1等位基因在162例头颈癌患者的综合系列中确定,其中83例来自芬兰的连续尸体器官供体作为对照。 DRB1 * 03与淋巴结阴性疾病相关,DRB1 * 08和13与小肿瘤相关。 DRB1 * 04具有预防疾病复发的作用。在这项研究中,大多数具有重要意义的等位基因在宫颈癌中的作用相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号